MétaCan
Menu
← Back to cohort
Record W4415566031 · doi:10.1017/cjn.2025.10423

Melatonin Compared to Other Treatments for Episodic Migraine: A Systematic Review and Network Meta-Analysis

2025· article· en· W4415566031 on OpenAlexvenueno aff
Felipe Araújo Gouhie, Davi Alves Silva, Beatriz Rizzo Parreira, Lucas Figueira Vieira, Caio Luiz Nazar Cunha, Ana Clara Nogueira Cezar

Bibliographic record

VenueCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2025
Typearticle
Languageen
FieldMedicine
TopicMigraine and Headache Studies
Canadian institutionsnot available
Fundersnot available
KeywordsMelatoninMelatonin receptorDiseasePathophysiologyMeta-analysisSystematic review

Abstract

fetched live from OpenAlex

INTRODUCTION: Migraine is one of the most common neurological diseases, presenting different characteristics among patients. Therefore, there is a need to identify preventive medications that offer more efficacy and fewer adverse effects. Melatonin is a promising therapeutic alternative in this context due to its analgesic, neuromodulatory and cerebral blood flow regulatory mechanism. OBJECTIVE: This study aims to evaluate the efficacy of melatonin treatment compared to placebo and other drugs in reducing migraine episodes' frequency and secondary outcomes by analyzing randomized clinical trials. METHODS: The databases Cochrane, Embase and PubMed were used to search and select relevant studies, according to their specific inclusion criteria. Afterward, the relevant data was extracted, and statistical analysis was conducted with R Studio version 4.3.1, applying appropriate models to maintain heterogeneity within them and produce a combined estimate. Results were interpreted considering potential biases and limitations to form our final statement with the Risk of Bias (RoB 2.0) tool from Cochrane. RESULTS: A total of nine studies involving 783 patients were included in our analysis. Treatment methods were composed of seven different strategies. The network meta-analysis showed no statistically significant differences related to monthly headache frequency between melatonin and amitriptyline (SD: -1.8; 95% Crl [-5.2, 1.0]); naproxen (SD: -0.98; 95% Crl [-5.5, 3.8]); valproic acid (SD: -0.60; 95% Crl [-5., 3.6]); topiramate (SD: 0.081; 95% Crl [-5.0, 4.7]); propanolol (SD: 1.4; 95% Crl [-3.7, 6.6]) and placebo (SD: 0.49; 95% Crl [-1.6, 2.7]). Other outcomes assessed were the MIDAS score, the mean number of analgesics used and headache duration, in hours, all of which had nonsignificant differences among treatment arms. CONCLUSION: This systematic review and network meta-analysis found no substantial support for the efficacy of melatonin treatment in patients with episodic migraine, challenging the assumption of their correlation. Although the results showed no significant association between the disease and melatonin administration, more research is necessary to explore the influence of melatonin in migraine's pathophysiology and further potential indirect mechanisms by which melatonin usage could benefit those who have not responded to conventional therapies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.027
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.019
Threshold uncertainty score0.071

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0130.027
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0190.040
Bibliometrics0.0070.006
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0020.002
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.095
GPT teacher head0.348
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques→Same topicMigraine and Headache Studies→French-language works237,207→